IL17A and nervous system disorder: In the present study, we demonstrated that Kv1.3 blockade effectively promoted OPC proliferation and differentiation through activation of AKT signaling, leading to protection of myelin from IL-17– and LPC- induced myelin damage in vitro and in vivo, which is beneficial to remyelination in neurological disorders with demyelination.